EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content
All Cell Therapies > Cell Therapy Card
Sign in for full access

Bone marrow-derived CD133+ progenitor cells for treatment of resistant angina

The aim of this study is to evaluate the therapeutic efficacy of intramyocardial administration of autologous CD133+ cells in patients with angina resistant to pharmacological treatment and without the possibility of effective revascularization.

No additional information regarding the therapeutic cells was provided by the sponsor.
See additional Cell Therapies for: Heart
Bone marrow-derived CD133+ progenitor cells for treatment of resistant angina
Home
Contact Us
About Terms of Use Privacy Policy
Copyright LifeMap Sciences, Inc. - All Rights Reserved (v4.14 Build 1)
This site does not provide medical advice and is for research use only